GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Mitsubishi Chemical Group Corp (TSE:4188) » Definitions » EBIT

Mitsubishi Chemical Group (TSE:4188) EBIT : 円290,239 Mil (TTM As of Mar. 2024)


View and export this data going back to 2005. Start your Free Trial

What is Mitsubishi Chemical Group EBIT?

Mitsubishi Chemical Group's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2024 was 円59,790 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2024 was 円290,239 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Mitsubishi Chemical Group's annualized ROC % for the quarter that ended in Mar. 2024 was 2.62%. Mitsubishi Chemical Group's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 8.73%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Mitsubishi Chemical Group's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 9.74%.


Mitsubishi Chemical Group EBIT Historical Data

The historical data trend for Mitsubishi Chemical Group's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mitsubishi Chemical Group EBIT Chart

Mitsubishi Chemical Group Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 151,491.00 55,770.00 312,562.00 199,354.00 285,627.00

Mitsubishi Chemical Group Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 138,699.00 80,151.00 73,228.00 77,070.00 59,790.00

Competitive Comparison of Mitsubishi Chemical Group's EBIT

For the Specialty Chemicals subindustry, Mitsubishi Chemical Group's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mitsubishi Chemical Group's EV-to-EBIT Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Mitsubishi Chemical Group's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Mitsubishi Chemical Group's EV-to-EBIT falls into.



Mitsubishi Chemical Group EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円290,239 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mitsubishi Chemical Group  (TSE:4188) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Mitsubishi Chemical Group's annualized ROC % for the quarter that ended in Mar. 2024 is calculated as:

ROC % (Q: Mar. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2023 ) + Invested Capital (Q: Mar. 2024 ))/ count )
=191752 * ( 1 - 29.94% )/( (5040181 + 5202363)/ 2 )
=134341.4512/5121272
=2.62 %

where

Invested Capital(Q: Dec. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=5984611 - 507536 - ( 436894 - max(0, 1691336 - 2259005+436894))
=5040181

Invested Capital(Q: Mar. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=6104513 - 524422 - ( 377728 - max(0, 1724912 - 2191636+377728))
=5202363

Note: The Operating Income data used here is four times the quarterly (Mar. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Mitsubishi Chemical Group's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2023  Q: Mar. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=239160/( ( (1953034 + max(788573, 0)) + (2043330 + max(694303, 0)) )/ 2 )
=239160/( ( 2741607 + 2737633 )/ 2 )
=239160/2739620
=8.73 %

where Working Capital is:

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(818177 + 799601 + 204333) - (507536 + 0 + 526002)
=788573

Working Capital(Q: Mar. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(852353 + 799249 + 162306) - (524422 + 0 + 595183)
=694303

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Mitsubishi Chemical Group's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2024 )
=290239/2979558.462
=9.74 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mitsubishi Chemical Group EBIT Related Terms

Thank you for viewing the detailed overview of Mitsubishi Chemical Group's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Mitsubishi Chemical Group (TSE:4188) Business Description

Traded in Other Exchanges
Address
1-1 Marunouchi 1-chome, Chiyoda-ku, Tokyo, JPN, 100-8251
Mitsubishi Chemical Group Corp is a holdings company, which manufactures and sells chemicals, plastics, and pharmaceuticals. It organizes itself into three segments based on product. The Industrial Materials segment, which generates the majority of revenue, sells chemicals and polymers, including industrial gases, petrochemicals, thermoplastics, polyethylene, and polypropylene. The Performance Products segment sells electronics and designed materials, including LED lighting and equipment, specialty chemicals, polyester and industrial films, and fibers. The Health Care segment sells pharmaceuticals to treat autoimmune diseases, diabetes and kidney diseases, central nervous system treatments, and vaccines. The majority of revenue comes from Japan.

Mitsubishi Chemical Group (TSE:4188) Headlines

No Headlines